One concrete data point for the thread. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.
One thing that is still open after NurseKim_ATL’s answer:
Whether anyone has held at a sub-maximal dose long term and kept the result, or whether the maintenance data only exists at 2.4mg?
BethLabQueen said:Worth knowing that the injection site changes very little.
Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsBethLabQueen said:Worth knowing that the injection site changes very little.
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
BethLabQueen said:Worth knowing that the injection site changes very little.
Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.